Stockscreener 앱 받기
1.08
0.92%
-0.01
시간 외 거래:
1.09
0.01
+0.93%
Enlivex Ltd 주식(ENLV)의 최신 뉴스
EBIT per share of Enlivex Ltd. – LS:A119KH - TradingView
Sentiment Recap: How does Enlivex Therapeutics Ltd score in quality rankings2026 Spike Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Nasdaq Moves: Can Enlivex Therapeutics Ltd reach all time highs this year - baoquankhu1.vn
[Form 3] Enlivex Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Enlivex (ENLV) CFO discloses initial share and option holdings - Stock Titan
Enlivex (ENLV) director Hart Gili reports option and share holdings - Stock Titan
Enlivex (ENLV) director discloses major share and option stake - Stock Titan
Enlivex (NASDAQ: ENLV) director discloses share and option stake - Stock Titan
Enlivex (ENLV) CMO discloses initial share and stock option holdings - Stock Titan
Published on: 2026-03-17 18:55:28 - baoquankhu1.vn
Operating cash flow per share of Enlivex Ltd. – SWB:1BT - TradingView
Enlivex Therapeutics Ltd expected to post a loss of 16 cents a shareEarnings Preview - TradingView
ENLV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Palm Beach Daily News
Enlivex Therapeutics (NASDAQ:ENLV) Rating Increased to Hold at Wall Street Zen - Defense World
Enlivex Ltd.: Target Price Consensus and Analysts Recommendations | 1BT | IL0011319527 - marketscreener.com
Enlivex Ltd.: Financial Data Forecasts Estimates and Expectations | 1BT | IL0011319527 - marketscreener.com
1BT: Static price chart | Enlivex Ltd. | IL0011319527 - marketscreener.com
Enlivex Ltd.: Dividend historical data and projections - marketscreener.com
Enlivex Ltd.: Revenue and Earnings Analysts Forecasts Revisions | 1BT | IL0011319527 - marketscreener.com
Enlivex Ltd.: Performance & Quotes, 1BT Stock Price on Börse Stuttgart Exchange - marketscreener.com
Enlivex Ltd.: Target Price Consensus and Analysts Recommendations | ENLV | IL0011319527 - marketscreener.com
Enlivex Ltd.: Revenue and Earnings Analysts Forecasts Revisions | ENLV | IL0011319527 - marketscreener.com
Enlivex Ltd.: Shareholders Board Members Managers and Company Profile | IL0011319527 - marketscreener.com
Enlivex (ENLV) Stock Analysis Report | Financials & Insights - Benzinga Japan
Enlivex Ltd.: Financial Data Forecasts Estimates and Expectations | ENLV | IL0011319527 - marketscreener.com
ENLV: Static price chart | Enlivex Ltd. | IL0011319527 - marketscreener.com
Enlivex Ltd.: Performance & Quotes, ENLV Stock Price on Nasdaq Exchange - marketscreener.com
Enlivex Rebrands as Enlivex Ltd. Following Shareholder Approval - The Globe and Mail
Aug Closing: Is Enlivex Therapeutics Ltd forming a bullish divergenceIndex Update & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Enlivex (ENLV) shareholders approve and complete corporate name change - Stock Titan
Enlivex Therapeutics (ENLV) to Release Quarterly Earnings on Wednesday - Defense World
Can Enlivex Therapeutics Ltd. reach all time highs this yearJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - mfd.ru
Enlivex Therapeutics Ltd. (ENLV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Drivers: Is QVCGB stock overvalued or fairly pricedWeekly Gains Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
ENLV to Participate in Virtual Meeting Hosted by BTIG - GuruFocus
Will Enlivex Therapeutics Ltd. stock benefit from infrastructure spendingForecast Cut & Short-Term High Return Ideas - mfd.ru
Enlivex Therapeutics (NASDAQ:ENLV) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Volatile Outlook for Enlivex Therapeutics as Investors Await Clinical Catalysts - Born2Invest
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Short Interest Update - MarketBeat
Enlivex Therapeutics announces new listing of RAIN token on Kraken - Yahoo Finance
Activity Recap: What are Enlivex Therapeutics Ltd.’s growth leversBear Alert & Free Verified High Yield Trade Plans - mfd.ru
Will Enlivex Therapeutics Ltd. outperform its industry peers2025 Investor Takeaways & Technical Pattern Based Signals - mfd.ru
Enlivex Completes $212 Million Private Placement, Expands Digital Asset Strategy - MSN
Enlivex Therapeutics (ENLV) Expands RAIN Token Accessibility wit - GuruFocus
Enlivex’s RAIN Treasury Token Debuts on Kraken to Boost Liquidity - TipRanks
Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange - The Manila Times
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Asheville Citizen Times
Enlivex Shareholders Approve Amended Articles of Association at February 3 Meeting - The Globe and Mail
Enlivex Completes Private Placement to Fund Digital Asset Strategy - MSN
1.20%
0.06%
자본화:
|
볼륨(24시간):